Węsierska-Gądek, J., Zulehner, N., Ferk, F., Składanowski, A., Komina, O., & Maurer, M. (2012). PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells(). Elsevier Science.

Węsierska-Gądek, Józefa, Nora Zulehner, Franziska Ferk, Andrzej Składanowski, Oxana Komina, et Margarita Maurer. PARP Inhibition Potentiates the Cytotoxic Activity of C-1305, a Selective Inhibitor of Topoisomerase II, in Human BRCA1-positive Breast Cancer Cells(). Elsevier Science, 2012.

Węsierska-Gądek, Józefa, et al. PARP Inhibition Potentiates the Cytotoxic Activity of C-1305, a Selective Inhibitor of Topoisomerase II, in Human BRCA1-positive Breast Cancer Cells(). Elsevier Science, 2012.